Open AccessA phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM)
Author(s) -
Lionel Adès,
Agnès GuerciBresler,
Pascale ConyMakhoul,
Laurence Legros,
Marie Sébert,
Thorsten Braun,
Jacques Delaunay,
Kristell Desseaux,
Sylvie Chevret,
Pierre Fenaux
Publication year - 2018
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2018.203885
Subject(s) - myelodysplastic syndromes , medicine , schedule , oncology , french , computer science , linguistics , philosophy , bone marrow , operating system